- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03260309
The Influence of Perioperative Optimisation to the Hip Arthroplasty Outcomes
August 25, 2017 updated by: Darius Cincikas, Vilnius University
The Influence of Perioperative Optimisation to the Primary Hip Arthroplasty Outcomes
Success of the hip arthroplasty depends on the measures that optimize perioperative conditions.It is planned to evaluate semi-closed loop system in the hip arthroplasty surgery.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Success of the total hip arthroplasty depends on the measures that optimize perioperative conditions.
They increase the emotional stress of the staff and error probability.
It is planned to evaluate semi-closed loop infusion system, its adaption for infusion application's influence to near and far treatment outcomes done by prospective randomized clinical trial.
This is done by performing total hip arthroplasty.
It's expected to evaluate the semi-closed loop system's influence on the doctor's emotional tension during the decision making.
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with osteoarthritis of the hip undergoing hip arthroplasty with spinal - epidural anesthesia
- Age >50 and <85 years
- ASA (American Society of Anesthesiology Classification) II physical status
- Start of operation no later than 09:00
- Signed informed consent form
Exclusion Criteria:
- Age <50 and >85 yers
- BMI (Body Mass Index) <20 and >40 kg/m2
- ASA I and ASA>II physical status
- History of a bleeding disorder
- Anemia before surgery Hb<110 g/l
- Intravascular fluid infusion within 24 hours before study
- Diabetes mellitus
- Previous open hip surgery
- Psychiatric illness (intake of other psychiatric medication than selective serotonin reuptake inhibitors)
- Alcohol intake 5 U daily
- Contraindication to spinal - epidural anesthesia
- Surgery not by project surgeon
- Start of operation later than 09:00
- Atrial fibrillation
- Narcotic addiction
- History of DVT (Deep Vein Thrombosis), thromboembolic complications, acute cardiac insufficiency
- Participation in the other study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: semi-closed system group
Semi-closed loop infusion system tactic.
Programmed iv fluid and blood infusion system ,,Belmont Rapid Infuser" and programmable syringe pump for adrenaline infusion.
|
Semi -closed loop infusion system tactic.Use volume loading test twice (before surgery and 12hrs postoperatively).
Computer provides advisory hypotension treatment algorithm.
Computer provides advisory anemia treatment algorithm.
Programmed iv fluid and blood infusions system ,,Belmont Rapid Infuser" and programmable syringe pump for adrenaline infusion.
|
|
Experimental: control group
Routine infusion therapy tactic
|
Routine re-hydration bolus before surgery.
Routine treatment of hypotension.
Routine treatment of anemia.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The efficiency of semi-closed loop infusion system
Time Frame: Before the surgery and 12 hrs postoperatively
|
Determine the ratio of doctor's approved and rejected computer suggestions
|
Before the surgery and 12 hrs postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perioperative blood loss
Time Frame: Before (baseline) the surgery,during surgery and 24hrs postoperatively
|
Non-invasive measurement of Hb (Masimo technology).
Laboratory hemoglobin determination, evaluation of the bleeding volume
|
Before (baseline) the surgery,during surgery and 24hrs postoperatively
|
|
Coagulation activity
Time Frame: Before (baseline) the surgery and 24hrs postoperatively
|
Coagulation activity is investigated thromboelastically
|
Before (baseline) the surgery and 24hrs postoperatively
|
|
Infused fluid and red blood cell volume
Time Frame: Before the surgery and 24hrs postoperatively
|
Repeated rehydration bolus (sol.Ringeri 2,5ml/kg), supportive fluid infusion (sol.NaCl 0,9% 1,5 ml/kg/hrs); evaluation of signs of anemia intolerance if Hb < 110 g/l
|
Before the surgery and 24hrs postoperatively
|
|
Wound healing
Time Frame: Within 6 days postoperatively
|
Evaluation of wound tissue condition, measurement of drainage fluid volume
|
Within 6 days postoperatively
|
|
Dosage physical exercise sample
Time Frame: Within 6 days postoperatively
|
Timed up and go test
|
Within 6 days postoperatively
|
|
Haemodynamic stability
Time Frame: Before (baseline) the surgery and 12 hrs postoperatively
|
Invasive measurement of arterial blood pressure
|
Before (baseline) the surgery and 12 hrs postoperatively
|
|
Complications
Time Frame: Within 6 days postoperatively
|
Registration of all complications
|
Within 6 days postoperatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Andrijauskas Audrius, PhD, Vilnius University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2013
Primary Completion (Actual)
June 1, 2017
Study Completion (Actual)
July 1, 2017
Study Registration Dates
First Submitted
February 29, 2016
First Submitted That Met QC Criteria
August 21, 2017
First Posted (Actual)
August 24, 2017
Study Record Updates
Last Update Posted (Actual)
August 28, 2017
Last Update Submitted That Met QC Criteria
August 25, 2017
Last Verified
August 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- VilniusU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hip Osteoarthritis
-
Poznan University of Medical SciencesRecruitingHip Pain Chronic | Hip Osteoarthritis | Hip ArthropathyPoland
-
University of MiamiNot yet recruiting
-
Poznan University of Medical SciencesNot yet recruitingHip Osteoarthritis | Arthropathy of HipPoland
-
Poznan University of Medical SciencesRecruitingHip Pain Chronic | Hip OsteoarthritisPoland
-
Poznan University of Medical SciencesNot yet recruitingHip Osteoarthritis | Arthropathy of HipPoland
-
Poznan University of Medical SciencesRecruiting
-
Tulip MedicineCompletedRehabilitation | Hip Osteoarthritis | Hip Arthroplasty Replacement | Hip Arthroplasty, TotalKazakhstan
-
Istituto Ortopedico RizzoliCompleted
-
Poznan University of Medical SciencesNot yet recruitingHip Osteoarthritis
-
Artvin Coruh UniversityCompletedHip OsteoarthritisTurkey (Türkiye)
Clinical Trials on Semi-closed loop infusion system tactic.
-
Zhonghua Chen,MDCompletedThe Effect of BIS Closed-loop Target Control on Postoperative OperationChina
-
KVG Medical College and HospitalUnknown
-
University of MinnesotaRecruitingStimulant Use DisorderUnited States
-
Hospital Clinic of BarcelonaUniversitat de Girona; Universitat Politècnica de ValènciaCompletedDiabetes Mellitus, Type 1Spain
-
Fundación para la Investigación del Hospital Clínico...Hospital Clinic of Barcelona; Universitat de Girona; Universitat Politècnica...CompletedDiabetes Mellitus, Type 1Spain
-
Centre Hospitalier du LuxembourgUniversity of Cambridge; Luxembourg Institute of HealthCompletedType1 Diabetes MellitusLuxembourg
-
Medtronic DiabetesWithdrawn
-
Rabin Medical CenterCompleted
-
Rabin Medical CenterMedtronicCompleted